RESUMEN
The study of new indirect methods for mastitis detection is of great relevance both at the economic level of the farm and dairies, and in terms of consumer health, and animal welfare. These methods help us to monitor the disease and speed up the decision-making process on treatment of the affected animal and the destination of the milk. The main aim of this work was to study the effect of intramammary infection and other non-infectious factors on the activity of the enzyme N-acetyl-ß-D-glucosaminidase (NAGase) in milk, in order to evaluate its use as an indicator for the early diagnosis of mastitis in sheep that could be less expensive, easier to measure and a better marker of inflammation or complementary to existing methods such as somatic cell count (SCC). Seven biweekly samplings were carried out, in which NAGase activity, SCC and milk were analyzed. Glands were classified according to their sanitary status based on the results of the SCC and bacteriological analysis. Non-infectious factors such as lactation stage, parity number and milking session had a statistically significant effect on NAGase values, finding the highest NAGase values at the onset and end of the study, in infectious mastitic glands of multiparous females and at morning milking. However, among the NAGase variation factors studied, the health status of the gland was the factor that caused the highest variation in enzyme levels, with infectious mastitic glands showing higher values than healthy glands. The predictive ability of NAGase was also studied by means of several logistic regression models, with the one that included NAGase together with lactation stage and parity obtaining the best results if sensitivity is to be prioritized, or the model that included NAGase, lactation stage, parity, milking and production if specificity is to be prioritized. From the results obtained, it can be concluded that the use of NAGase as an intramammary infection detection method in sheep can be useful when non-infectious factors that cause changes in the concentration of the enzyme are also considered.
Asunto(s)
Enfermedades de los Bovinos , Mastitis Bovina , Enfermedades de las Ovejas , Embarazo , Femenino , Bovinos , Ovinos , Animales , Acetilglucosaminidasa/análisis , Mastitis Bovina/diagnóstico , Leche/química , Lactancia , Recuento de Células/veterinaria , Glándulas Mamarias Animales , Enfermedades de las Ovejas/diagnósticoRESUMEN
Purpose: To illustrate the diagnosis and management of an atypical, cyst-like recurrence of retinoblastoma. Observations: A 4-month-old boy was diagnosed with Group B retinoblastoma in the right eye, consisting of a 10 x 9 × 3.6 mm retinal tumor temporal to the macula. He was treated with one session of intra-arterial ophthalmic artery chemotherapy using melphalan, followed by three sessions of diode laser transpupillary thermotherapy (TTT), after which complete tumor regression was achieved. 45 weeks after initial treatment, a cystic lesion was detected adjacent to superior margin of the regressed tumor scar. The differential diagnosis included pigment epithelial detachment, retinal gliosis, secondary retinoschisis, and local tumor recurrence. Multimodal imaging including OCT angiography confirmed the diagnosis of local recurrence manifesting as a vascularized cyst-like lesion. Two additional sessions of TTT achieved sustained tumor regression through 16 months of additional follow-up. Conclusions and Importance: Recurrence of retinoblastoma following chemotherapy typically manifests as enlargement of a previously regressed tumor, or seeding into the vitreous or subretinal space. An unusual cyst-like recurrence of retinoblastoma at the margin of a previously regressed tumor was diagnosed by multimodal imaging. Focal diode laser transpupillary thermotherapy was curative.
RESUMEN
INTRODUCTION: Manual therapy has been shown to reduce self-reported symptoms in patients with chronic tension-type headache (CTTH). However, simultaneous application of suboccipital muscle inhibition and interferential current has not previously been investigated. This study evaluates the effectiveness of combined treatment with suboccipital muscle inhibition and interferential current compared to standard treatment for pain, disability, and headache impact in patients with CTTH. METHODS: Patients were randomly allocated to receive either standard treatment (n = 13) or the experimental treatment (n = 12), consisting of 20 minutes of suboccipital muscle inhibition plus interferential current twice weekly for 4 weeks. The primary outcome was improvement in pain, and secondary outcomes included improvement in headache-related disability and reduction in headache impact, which were assessed at baseline and at 4 weeks by a blinded rater. RESULTS: Statistical analysis showed improvements in the experimental treatment group at 4 weeks for headache-related disability (Neck Disability Index: Hedges' g = 1.01, P = .001; and Headache Disability Inventory: Hedges' g = 0.48, P = .022) and headache impact (6-item Headache Impact Test: Hedges' g = 0.15, P = .037) but not for self-reported pain (numerical rating scale: Hedges' g = 1.13, P = .18). CONCLUSIONS: Combined treatment with suboccipital muscle inhibition and interferential current in patients with CTTH did not significantly improve self-reported pain but did reduce disability and the impact of headache on daily life at 4 weeks. These improvements exceed the minimum clinically important difference, demonstrating the clinical relevance of our findings.
Asunto(s)
Manipulaciones Musculoesqueléticas , Cefalea de Tipo Tensional , Humanos , Cefalea de Tipo Tensional/terapia , Cefalea de Tipo Tensional/diagnóstico , Músculos del Cuello , Cefalea , DolorRESUMEN
Over the last years, an increasing concern has emerged regarding the eco-friendly management of wastewater. Apart from the role of wastewater treatment plants (WWTPs) for wastewater and sewage sludge treatment, the increasing need of the recovery of the resources contained in wastewater, such as nutrients and water, should be highlighted. This would allow for transforming a wastewater treatment plant (WWTP) into a sustainable technological system. The objective of this review is to propose a moving bed biofilm reactor (MBBR) as a novel technology that contributes to the circularity of the wastewater treatment sector according to the principles of circular economy. In this regard, this paper aims to consider the MBBR process as the initial step for water reuse, and nutrient removal and recovery, within the circular economy model.
Asunto(s)
Biopelículas , Aguas Residuales , Reactores Biológicos , Nutrientes , Aguas del Alcantarillado , Eliminación de Residuos LíquidosRESUMEN
While brain default mode network (DMN) activation in human subjects has been associated with mind wandering, meditation practice has been found to suppress it and to increase psychological well-being. In addition to DMN activity reduction, experienced meditators (EMs) during meditation practice show an increased connectivity between the DMN and the central executive network (CEN). However, the gradual change between DMN and CEN configuration from pre-meditation, during meditation, and post-meditation is unknown. Here, we investigated the change in DMN and CEN configuration by means of brain activity and functional connectivity (FC) analyses in EMs across three back-to-back functional magnetic resonance imaging (fMRI) scans: pre-meditation baseline (trait), meditation (state), and post-meditation (state-to-trait). Pre-meditation baseline group comparison was also performed between EMs and healthy controls (HCs). Meditation trait was characterized by a significant reduction in activity and FC within DMN and increased anticorrelations between DMN and CEN. Conversely, meditation state and meditation state-to-trait periods showed increased activity and FC within the DMN and between DMN and CEN. However, the latter anticorrelations were only present in EMs with limited practice. The interactions between networks during these states by means of positive diametric activity (PDA) of the fractional amplitude of low-frequency fluctuations (fALFFs) defined as [Formula: see text] revealed no trait differences but significant increases during meditation state that persisted in meditation state-to-trait. The gradual reconfiguration in DMN and CEN suggest a neural mechanism by which the CEN negatively regulates the DMN and is probably responsible for the long-term trait changes seen in meditators and reported psychological well-being.
Asunto(s)
Atención/fisiología , Encéfalo/diagnóstico por imagen , Meditación , Atención Plena , Red Nerviosa/diagnóstico por imagen , Adulto , Mapeo Encefálico/métodos , Femenino , Neuroimagen Funcional , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana EdadRESUMEN
BACKGROUND: Several studies have aimed to identify molecules that inhibit the toxic actions of snake venom phospholipases A2 (PLA2s). Studies carried out with PLA2 inhibitors (PLIs) have been shown to be efficient in this assignment. OBJECTIVE: This work aimed to analyze the interaction of peptides derived from Bothrops atrox PLIγ (atPLIγ) with a PLA2 and to evaluate the ability of these peptides to reduce phospholipase and myotoxic activities. METHODS: Peptides were subjected to molecular docking with a homologous Lys49 PLA2 from B. atrox venom modeled by homology. Phospholipase activity neutralization assay was performed with BthTX-II and different ratios of the peptides. A catalytically active and an inactive PLA2 were purified from the B. atrox venom and used together in the in vitro myotoxic activity neutralization experiments with the peptides. RESULTS: The peptides interacted with amino acids near the PLA2 hydrophobic channel and the loop that would be bound to calcium in Asp49 PLA2. They were able to reduce phospholipase activity and peptides DFCHNV and ATHEE reached the highest reduction levels, being these two peptides the best that also interacted in the in silico experiments. The peptides reduced the myotubes cell damage with a highlight for the DFCHNV peptide, which reduced by about 65%. It has been suggested that myotoxic activity reduction is related to the sites occupied in the PLA2 structure, which could corroborate the results observed in molecular docking. CONCLUSION: This study should contribute to the investigation of the potential of PLIs to inhibit the toxic effects of PLA2s.
Asunto(s)
Fosfolipasas A2 Grupo IV/antagonistas & inhibidores , Mioblastos/efectos de los fármacos , Péptidos/farmacología , Inhibidores de Fosfolipasa A2/farmacología , Animales , Bothrops , Células Cultivadas , Evaluación Preclínica de Medicamentos , Fosfolipasas A2 Grupo IV/aislamiento & purificación , Fosfolipasas A2 Grupo IV/metabolismo , Ratones , Modelos Moleculares , Péptidos/síntesis química , Péptidos/química , Inhibidores de Fosfolipasa A2/síntesis química , Inhibidores de Fosfolipasa A2/químicaRESUMEN
Ovalbumin is considered a protein of high nutritional value because it contains essential amino acids and is highly digestible. Therefore, it has a high biological value. Currently, the high food demand requires worldwide attention because food production is insufficient. Therefore, other alternatives are necessary to satisfy food demands, such as protein engineering. In this work, a protein with a high essential amino acid content similar to ovalbumin was synthesized by protein engineering, expressed, and digested in vitro. The assembly and sequential overlap extension PCR strategy was used to synthesize a 345-bp gene that encodes a high essential amino acid content protein (HEAAP). The 345-bp product was cloned into the vector pBAD TOPO®, and expressed in Escherichia coli BL21. PCR reactions and sequencing demonstrated the presence, orientation, and correct sequence of the insert. HEAAP expression was induced by L-arabinose and then purified using Ni-NTA affinity chromatography. The expression in E. coli was low and barely detected by Western blot assay. The in vitro multienzyme digestibility of HEAAP was around 79%, which suggests that the protein is potentially nutritious. Virtual analysis classifies the protein as unstable and hydrophilic, with a half-life in E. coli of 10 h. The recombinant HEAAP was successfully synthesized, but it is necessary to improve the digestibility and to optimize expression including selecting other expression models.
Asunto(s)
Ingeniería de Proteínas/métodos , Proteínas Recombinantes/síntesis química , Proteínas Recombinantes/aislamiento & purificación , Aminoácidos Esenciales/síntesis química , Aminoácidos Esenciales/fisiología , Cromatografía de Afinidad , Clonación Molecular/métodos , Suplementos Dietéticos , Escherichia coli/genética , Reacción en Cadena de la Polimerasa/métodos , Proteínas/síntesis química , Proteínas/aislamiento & purificación , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes/genéticaRESUMEN
Introducción: El fenómeno de flexión-relajación en columna cervical (FRc) no tiene la misma difusión clínica que el test lumbar. La respuesta de los músculos cervicales es menos evidente. Tanto el protocolo de evaluación como la instrumentación utilizada tienen influencia para alcanzar un valor de fiabilidad con validez clínica. Se plantea un estudio test-retest en 3 condiciones distintas, para definir un protocolo de valoración idóneo. Material y método: Se evalúan 3 grupos con 9, 11 y 10 voluntarios, respectivamente, en un test-retest efectuado con un intervalo entre 7 a 14 días. En el grupo i, se evalúa la prueba con electromiografía de superficie (EMGs) bipolar, sin control del movimiento. Para el grupo ii se usa electrodo bipolar, con control de la velocidad de ejecución y una leve ayuda para estabilizar el tronco. En el grupo iii, se controla la velocidad, se aumenta la estabilización y se usa un electrodo tetrapolar. Como variables de resultado se toman la ratio de flexión-relajación y su logaritmo neperiano. Se efectúa un test sentado con el tronco recto y otro en flexión a 45°. Resultados: Para el grupo iii las 4 variables obtienen valores en el coeficiente de correlación intraclase (ICC > 0,80). En el grupo ii, el ICC estaba comprendido entre 0,3-0,6. Para el grupo i, las 4 variables fueron muy inferiores a 0,3. Conclusión: Con una adecuada estabilización de la postura, control de la velocidad y adecuada instrumentación de la prueba, puede objetivarse una respuesta de FRc. Definir un protocolo fiable permite avanzar en el uso clínico del test
Introduction: The cervical flexion-relaxation phenomenon (FRP) is not as well-known as the lumbar test. The response of the cervical muscles is less evident. Both the ASSESSMENT protocol and the instrumentation used influence the achievement of a reliability value with clinical validity. We conducted a test-retest study in 3 different conditions, to define a suitable assessment protocol. Material and method: Three groups were evaluated with 9, 11 and 10 volunteers, respectively, in a test-retest study with an interval between 7 and 14 days. In group i, the test was assessed with a bipolar electrode of surface electromyography (EMGs) and without movement control. In group ii, we used a bipolar electrode, the speed of the movement was controlled and we introduced a slight help to stabilise the trunk. In group iii, speed was controlled, stabilisation was increased and a four-pole electrode was used. As outcome variables, we took the flexion-relaxation ratio and its neperian logarithm. A sitting test was performed with the trunk straight and another was conducted with 45° flexion. Results: In group iii, the 4 variables obtained intraclass correlation coefficient values with clinical validity (ICC > 0.80). In group ii, the ICC ranged from 0.3-0.6. In group i, the 4 variables were much lower than 0.3 Conclusion: A valid cervical FRP can be obtained with good stabilisation of posture, control of speed and suitable instrumentation of the test. Definition of a reliable protocol would increase the clinical use of the test
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Relajación/fisiología , Vértebras Cervicales/fisiología , Docilidad/fisiología , Rango del Movimiento Articular/fisiología , Rotación , Reproducibilidad de los Resultados , Reproducibilidad de los Resultados , Voluntarios Sanos/estadística & datos numéricos , Valores de ReferenciaRESUMEN
Paclitaxel (PTX) is currently used as a front-line chemotherapeutic agent for several types of cancer, including ovarian carcinoma; however, PTX-resistance frequently arises through multiple mechanisms. The development of new strategies using natural compounds and PTX in combination has been the aim of several prior studies, in order to enhance the efficacy of chemotherapy. In this study, we found the following: (i) gallic acid (GA), a phenolic compound, potentiated the capacity of PTX to decrease proliferation and to cause G2/M cycle arrest in the PTX-resistant A2780AD ovarian cancer cell line; (ii) GA exerted a pro-oxidant action by increasing the production of reactive oxygen species (ROS), and co-treatment with the antioxidant agent Nacetyl-Lcysteine (NAC) prevented GA+PTX-induced cell proliferation inhibition and G2/M phase arrest; (iii) PTX stimulated ERK phosphorylation/activation, and co-treatment with the MEK/ERK inhibitor PD98049 potentiated the proliferation inhibition and G2/M phase arrest; (iv) and finally, GA abrogated the PTX-induced stimulation of ERK phosphorylation, a response that was prevented by co-treatment with NAC. Taken together, these results indicate that GA sensitizes PTX-resistant ovarian carcinoma cells via the ROSmediated inactivation of ERK, and suggest that GA could represent a useful co-adjuvant to PTX in ovarian carcinoma treatment.
Asunto(s)
Regulación hacia Abajo , Resistencia a Antineoplásicos/efectos de los fármacos , Ácido Gálico/farmacología , Neoplasias Ováricas/metabolismo , Paclitaxel/farmacología , Especies Reactivas de Oxígeno/metabolismo , Acetilcisteína/farmacología , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Sinergismo Farmacológico , Activación Enzimática , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Femenino , Puntos de Control de la Fase G2 del Ciclo Celular , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Neoplasias Ováricas/tratamiento farmacológicoRESUMEN
PURPOSE: Studies have found that pomegranate juice (PJ) consumption increases the binding of high-density lipoproteins (HDL) to paraoxonase 1 (PON1), thus increasing the catalytic activity of this enzyme. PON1 is an antioxidant arylesterase synthesized in the liver and transported in plasma in association with HDL. Decreased levels of PON1 are associated with higher levels of cholesterol. We determined the effects of PJ on body weight, cholesterol, and triacylglycerols through 5 months of supplementation. In addition, the effect of PJ on pon1 gene expression in the liver was also measured by RT-qPCR as well as the activity in serum by a semiautomated method using paraoxon as a substrate. METHODS: CD-1 mice were either fed a control diet or were fed a high-fat diet 1.25% (wt/wt) cholesterol, 0.5% (wt/wt) sodium cholate, and 15% (wt/wt) saturated fat. 300 µL of PJ containing 0.35 mmol total polyphenols was administered by oral gavage to half of the high fat mice daily. The rest of the high fat mice and the control mice were administered with 300 µL of water. RESULTS: PJ-supplemented animals had significantly higher levels of expression of pon1 compared to the unsupplemented group. PJ-supplemented animals had twice the PON1 activity of the unsupplemented group. In addition, PJ-supplemented animals had the lowest body weight and significantly reduced cholesterol and triacylglycerol levels, although the tricylglycerol levels were not consistently decreased. CONCLUSIONS: These results suggest that PJ protects against the effects of a high-fat diet in body weight, and cholesterol levels.
Asunto(s)
Arildialquilfosfatasa/sangre , Arildialquilfosfatasa/genética , Dieta Alta en Grasa/efectos adversos , Jugos de Frutas y Vegetales , Frutas , Lythraceae , Animales , Peso Corporal , Colesterol/sangre , Suplementos Dietéticos , Expresión Génica , Hígado/química , Ratones , ARN Mensajero/análisis , Triglicéridos/sangreRESUMEN
Procedures to characterize drugs that can be obtained from plant extracts or combinatorial chemistry are tedious, and they consume considerable resources (e.g., animals) and time. Thus, we have looked for a way to streamline this process. We describe here a novel system for the pre-characterization of drugs based on liquid chromatography coupled to biological detection using perifused or perfused organs. This novel system allows the on-line detection of pharmacologically active substances in hydrosoluble mixtures from vegetal extracts or combinatorial chemistry libraries. Depending on the volume of drug solution and concentration of the samples, the procedure can work through either medium pressure liquid chromatography or HPLC, and it enables the fingerprints of drugs to be assessed based on their contractile activity on combinations of different isolated tissues. As an example, we show how the system can identify active fractions from an extract of Stevia rebaudiana Bertoni, an activity that was later associated with rebaudioside N. Coupling liquid chromatography to biological detection offers a rapid way to focus attention on active products in complex samples, mostly from hydrosoluble species, helping to considerably reduce the time and cost of the pre-characterization of drugs.
Asunto(s)
Descubrimiento de Drogas/métodos , Extractos Vegetales/análisis , Stevia , Animales , Cromatografía Liquida/métodos , Técnicas de Cultivo de Órganos , Extractos Vegetales/metabolismo , Ratas , Ratas Sprague-Dawley , Distribución Tisular/fisiologíaRESUMEN
Dichrostachys cinerea (L.) Wight & Arn. is a tropical leguminous shrub widely regarded as an invasive species in Cuba, after having invaded a significant proportion of its arable land during the past decades. Concurrently, smallholder pig producers are highly constrained by the scarcity of protein feeds. This study aimed to assess the feeding value of D. cinerea pod meal (DCPM) as an alternative protein supplement for pigs in Cuban smallholder production systems. An on-farm feeding trial was carried out with three groups (N = 10) of growing-fattening pigs over 60 days, where DCPM replaced 0, 15, and 30% in DM of a dietary commercial concentrate. Then, in an in vivo digestibility trial with eight growing pigs, apparent digestibilities of DCPM were determined for dry matter (DM), organic matter (OM) and crude protein (CP). Finally, in vitro digestibilities for OM (fecal and ileal) and CP (ileal) were determined. In the feeding trial, pig body weight gains were not affected by increased dietary substitution levels of concentrate for DCPM. Blood parameters, with a few exceptions, did not show significant differences among groups. Values for in vivo OM and CP digestibilities were 40.81 and 50.26%, and substantially higher than in vitro values. In conclusion, our results showed that at least 30% of DM in commercial concentrate could be substituted by DCPM without affecting pig growth performances under Cuban smallholder conditions. The low digestibility of DCPM is, however, not acceptable for intensive pig production systems. In vitro enzyme digestibility methods developed for commercial pig feeds are not suitable for DCPM without further calibration.
Asunto(s)
Dieta/veterinaria , Suplementos Dietéticos , Digestión , Fabaceae/química , Sus scrofa/fisiología , Aumento de Peso , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Cuba , Femenino , Masculino , Sus scrofa/sangre , Sus scrofa/crecimiento & desarrolloRESUMEN
PURPOSE: Obesity increases the risk of cardiovascular disease, type 2 diabetes mellitus and cancer development. Autophagy and apoptosis are critical processes for development and homeostasis in multicellular organisms and have been linked to a variety of disorders. We aimed to investigate whether the quantity and quality of dietary fat can influence these processes in the adipose tissue of obese people. METHODS: A randomized, controlled trial within the LIPGENE study assigned 39 obese people with metabolic syndrome to 1 of 4 diets: (a) a high-saturated fatty acid diet, (b) a high-monounsaturated fatty acid (HMUFA) diet, and (c, d) two low-fat, high-complex carbohydrate diets supplemented with long-chain n-3 polyunsaturated fatty acids (LFHCC n-3) or placebo (LFHCC), for 12 weeks each. RESULTS: We found an increase in the expression of autophagy-related BECN1 and ATG7 genes after the long-term consumption of the HMUFA diet (p = 0.001 and p = 0.004, respectively) and an increase in the expression of the apoptosis-related CASP3 gene after the long-term consumption of the LFHCC and LFHCC n-3 diets (p = 0.001 and p = 0.029, respectively). CASP3 and CASP7 gene expression changes correlated with HOMA index. CONCLUSION: Our results suggest that the processes of autophagy and apoptosis in adipose tissue may be modified by diet and that the consumption of a diet rich in monounsaturated fat may contribute to adipose tissue homeostasis by increasing autophagy. They also reinforce the notion that apoptosis in adipose tissue is linked to insulin resistance. CLINICAL TRIAL REGISTRATION NUMBER: ClinicalTrials.gov NCT00429195.
Asunto(s)
Adipocitos/citología , Tejido Adiposo/fisiopatología , Apoptosis , Autofagia , Grasas de la Dieta/administración & dosificación , Adulto , Anciano , Proteína 7 Relacionada con la Autofagia/genética , Proteína 7 Relacionada con la Autofagia/metabolismo , Beclina-1/genética , Beclina-1/metabolismo , Glucemia/metabolismo , Caspasa 3/genética , Caspasa 3/metabolismo , Caspasa 7/genética , Caspasa 7/metabolismo , Dieta con Restricción de Grasas , Dieta Alta en Grasa , Ácidos Grasos/administración & dosificación , Ácidos Grasos Monoinsaturados/administración & dosificación , Ácidos Grasos Omega-3/administración & dosificación , Femenino , Regulación de la Expresión Génica , Homeostasis , Humanos , Resistencia a la Insulina , Masculino , Síndrome Metabólico/fisiopatología , Persona de Mediana Edad , Obesidad/fisiopatología , Método Simple CiegoRESUMEN
Four natural analogues of podophyllotoxin obtained from the Mexican medicinal plant Bursera fagaroides, namely, acetyl podophyllotoxin (2), 5'-desmethoxy-ß-peltatin A methyl ether (3), 7',8'-dehydro acetyl podophyllotoxin (4), and burseranin (5), have been characterized, and their interactions with tubulin have been investigated. Cytotoxic activity measurements, followed by immunofluorescence microscopy and flow cytometry studies, demonstrated that these compounds disrupt microtubule networks in cells and cause cell cycle arrest in the G2/M phase in the A549 cell line. A tubulin binding assay showed that compounds 1-4 were potent assembly inhibitors, displaying binding to the colchicine site with Kb values ranging from 11.75 to 185.0 × 10(5) M(-1). In contrast, burseranin (5) was not able to inhibit tubulin assembly. From the structural perspective, the ligand-binding epitopes of compounds 1-3 have been mapped using STD-NMR, showing that B and E rings are the major points for interaction with the protein. The obtained results indicate that the inhibition of tubulin assembly of this family of compounds is more effective when there are at least two methoxyl groups at the E ring, along with a trans configuration of the lactone ring in the aryltetralin lignan core.
Asunto(s)
Bursera/química , Podofilotoxina/farmacología , Tubulina (Proteína)/metabolismo , Ciclo Celular/efectos de los fármacos , Colchicina/farmacología , Humanos , Lactonas/química , Lactonas/farmacología , Lignanos/farmacología , Microtúbulos/efectos de los fármacos , Estructura Molecular , Podofilotoxina/análogos & derivados , Podofilotoxina/química , Unión Proteica , Moduladores de Tubulina/química , Moduladores de Tubulina/farmacologíaRESUMEN
El dolor postoperatorio de intensidad alta o extrema tiene una incidencia publicada cercana al 30 % de los pacientes quirúrgicos, siendo su principal preocupación, incluso más relevante que los resultados satisfactorios o no que pudiera tener el procedimiento en la resolución de su enfermedad. Los AINE son los fármacos más prescritos en el mundo para el tratamiento del dolor agudo y crónico de diferentes causas. El ibuprofeno es un analgésico ampliamente utilizado en la prevención y tratamiento del dolor. Recientemente, su forma intravenosa ha sido aprobada por la FDA (www.accessdata.fda.gov) para el tratamiento del dolor leve a moderado y moderado a severo complementario a la analgesia opioide. Adicionalmente, ha sido aprobado para la reducción de la fiebre. Dado su potencial como adyuvante en la analgesia multimodal, se realizó una revisión acerca del uso perioperatorio del ibuprofeno intravenoso, analizando la literatura disponible en inglés y español en PubMed y Ovid MEDLINE hasta diciembre 2015. Se incluyeron datos farmacocinéticos y farmacodinámicos provenientes de pacientes de diferentes edades, así como estudios clínicos, incluyendo aquellos en los que se cuantificó el uso de opioides en el periodo postoperatorio, analizando la sinergia entre ambos tipos de analgésicos. El ibuprofeno intravenoso ofrece ventajas sobre la presentación oral, siendo una alternativa a la limitada disponibilidad de AINE endovenosos como parte de la analgesia multimodal perioperatoria (AU)
About 30 % of surgical patients report high or extreme intensity postoperative pain as their main concern, which is even more relevant than satisfactory surgery results. NSAIDs are the most commonly prescribed drugs worldwide for the treatment of acute and chronic pain. Ibuprofen is widely used in prevention and treatment of pain. Recently, intravenous ibuprofen has been approved by the FDA (www.accessdata.fda.gov) for the management of mild-moderate pain and management of moderate-severe pain complementary to opioid analgesia. Additionally, has been approved for fever reduction. Given its potential as adjuvant therapy in multimodal analgesia, a review of the perioperative use of intravenous ibuprofen was conducted by analyzing literature available in English and Spanish in PubMed and Ovid MEDLINE through December 2015. The review included pharmacokinetic and pharmacodynamic data from patients of different ages as well as clinical studies where the use of opioids was quantified in the postoperative period and the synergy between these two types of drugs was analyzed. Intravenous ibuprofen offers advantages over oral presentation and is an alternative to the limited availability of intravenous NSAIDs as part of multimodal perioperative analgesia (AU)
Asunto(s)
Humanos , Masculino , Femenino , Dolor Postoperatorio/tratamiento farmacológico , Ibuprofeno/metabolismo , Ibuprofeno/uso terapéutico , Manejo del Dolor/métodos , Manejo del Dolor , Antiinflamatorios no Esteroideos/uso terapéutico , Anestesia Intravenosa/métodos , Dolor Postoperatorio/rehabilitación , Cuidados Posoperatorios/métodos , Cuidados Posoperatorios/tendencias , Anestesia Intravenosa/instrumentación , Anestesia IntravenosaRESUMEN
El dolor postoperatorio de intensidad alta o extrema tiene una incidencia publicada cercana al 30 % de los pacientes quirúrgicos, siendo su principal preocupación, incluso más relevante que los resultado satisfactorios o no que pudiera tener el procedimiento en la resolución de su enfermedad. Los AINE son los fármacos más prescritos en el mundo para el tratamiento del dolor agudo y crónico de diferentes causas. El ibuprofeno es un analgésico ampliamente utilizado en la prevención y tratamiento del dolor. Recientemente, su forma intravenosa ha sido aprobada por a FDA (www.accessdata.fda.com) para el tratamiento del dolor leve a moderado y moderado a severo complementario a la analgesia opioide. Adicionalmente, ha sido aprobado para la reducción de la fiebre. Dado su potencial como adyuvante en la analgesia multimodal, se realizó una revisión acerca del uso perioperatorio del ibuprofeno intravenoso, analizando la literatura disponible en inglés y español en PubMed y Ovid MEDLINE hasta diciembre de 2015. Se incluyeron datos farmacocinéticos y farmacodinámicos provenientes de pacientes de diferentes edades, así como estudios clínicos, incluyendo aquellos en los que se cuantificó el uso de opioides en el periodo postoperatorio, analizando la sinergia entre ambos tipos de analgésicos. El ibuprofeno intravenoso ofrece ventajas sobre la presentación oral, siendo una alternativa a la limitada disponibilidad de AINE endovenoso como parte de la analgesia multimodal perioperatoria (AU)
About 30% of surgical patients report high or extreme intensity postoperative pain as their main concern, which is even more relevant than satisfactory surgery results. NSAIDs are the most commonly prescribed drugs worldwide for the treatment of acute and chronic pain, Ibuprofen is widely used in prevention and treatment of pain. Recently, intravenous ibuprofen has been approved by the FDA (www.accessdata.fda.gov) the management of mild-moderate pain and management of moderate-severe pain complementary to avoid analgesia. Additionally, has been approved for fever reduction. Give its potential as adjuvant therapy in multimodal analgesia, a review of perioperative use of intravenous ibuprofen was conducted by analysing literature available in English and Spanish in PubMed and Ovid MEDLINE through December 2015. The review included pharmacokinetic and pharmacodynamics data from patients of different ages as well as clinical studies where the use of opioids was quantified in the postoperative period and the synergy between these two types of drugs was analyzed. Intravenous ibuprofen offers advantages over oral presentation and is an alternative to the limited availability of intravenous NSAIDS as part of multimodal perioperative analgesia (AU)
Asunto(s)
Humanos , Ibuprofeno/administración & dosificación , Dolor Postoperatorio/tratamiento farmacológico , Procedimientos Quirúrgicos Ambulatorios/métodos , Administración Intravenosa , Antiinflamatorios no Esteroideos/uso terapéutico , Manejo del Dolor/métodosRESUMEN
The preweaning litter environment of gilts can affect subsequent development. In a recent experiment designed to test the effects of diet on gilt development, litter-of-origin traits including individual birth weights, immunocrits (a measure of colostrum intake), sow parity, number weaned, and individual weaning weights were collected for approximately 1,200 gilts that were progeny of approximately 300 sows. Subsequently, BW, LM area, and backfat were measured at 100 d of age and at 28-d intervals until slaughter (260 d of age). From 160 d of age to slaughter, gilts were observed daily for estrus. At slaughter, the reproductive tract and 1 mammary gland were recovered. The reproductive tract was classified as cyclic or prepubertal; the number of corpora lutea was counted. Uterine horn lengths and ovarian dimensions were measured. Uterus and ovary samples from every 10th gilt were prepared for histological evaluation of uterine gland development and follicle counts, respectively. Mammary gland tissue protein and fat were assayed. Day of the estrous cycle at slaughter was calculated using the first day of the most recent standing estrus (d 0) recorded previous to slaughter. Each gilt development trait was analyzed for association with each litter-of-origin trait, after adjusting for dietary treatment effects. Uterine length, ovarian dimensions, mammary gland protein and fat, and uterine gland development were also adjusted for day of the estrous cycle at slaughter. All litter-of-origin traits were associated ( < 0.05) with growth traits. Top-down (backward elimination) multiple regression analysis indicated that BW and LM accretion in gilts was positively associated with immunocrit ( < 0.01), birth weight ( < 0.01), preweaning growth rate ( < 0.01), and parity ( < 0.01). Backfat accretion was positively associated with preweaning growth rate ( < 0.01), number weaned ( < 0.05), and parity ( < 0.05). Age at puberty was associated with birth weight (positive; < 0.01) and preweaning growth rate (negative; < 0.01). Total uterine length was positively associated with only birth weights ( < 0.05). Mammary gland protein was negatively associated with preweaning growth ( < 0.01). Mammary gland fat was positively associated with birth weight and number of piglets weaned ( > 0.05). These results indicate that colostrum consumption, birth weights, preweaning growth rate, number weaned, and parity are associated with gilt development traits during later life.
Asunto(s)
Reproducción/fisiología , Maduración Sexual/fisiología , Porcinos/crecimiento & desarrollo , Animales , Peso al Nacer , Calostro , Dieta/veterinaria , Estro , Femenino , Paridad , Embarazo , Reproducción/genética , Maduración Sexual/genética , Porcinos/genética , DesteteRESUMEN
The cytotoxic activity and the chemical composition of the dichloromethane/methanol root extract of Linum scabrellum Planchon (Linaceae) were analyzed. Using NMR spectra and mass spectrometry analyses of the extract we identified eight main constituents: oleic acid (1), octadecenoic acid (2), stigmasterol (3), α-amyrin (4), pinoresinol (5), 6 methoxypodophyllotoxin (6), coniferin (7), and 6-methoxypodophyllotoxin-7-O-ß-D-glucopyranoside (8). By using the sulforhodamine B assay, an important cytotoxic activity against four human cancer cell lines, HF6 colon (IC50 = 0.57 µg/mL), MCF7 breast (IC50 = 0.56 µg/mL), PC3 prostate (IC50 = 1.60 µg/mL), and SiHa cervical (IC50 = 1.54 µg/mL), as well as toward the normal fibroblasts line HFS-30 IC50 = 1.02 µg/mL was demonstrated. Compound 6 (6-methoxypodophyllotoxin) was responsible for the cytotoxic activity exhibiting an IC50 value range of 0.0632 to 2.7433 µg/mL against the tested cell lines. Cell cycle studies with compound 6 exhibited a cell arrest in G2/M of the prostate PC3 cancer cell line. Microtubule disruption studies demonstrated that compound 6 inhibited the polymerization of tubulin through its binding to the colchicine site (binding constant K b = 7.6 × 10(6) M(-1)). A dose-response apoptotic effect was also observed. This work constitutes the first investigation reporting the chemical composition of L. scabrellum and the first study determining the mechanism of action of compound 6.
RESUMEN
The objective of this study was to determine if body composition of developing gilts could be altered at the onset of estrus by ad libitum feeding diets differing in standard ileal digestible (SID) lysine and ME using levels that are within those used in practice by pig producers in the United States. Crossbred Large White × Landrace gilts ( = 1,221), housed in groups, were randomly allotted to 6 corn-soybean diets in a 2 × 3 factorial arrangement formulated to provide 2 SID lysine and 3 ME levels. Gilts received grower diets formulated to provide 0.86 (low) or 1.02% (high) SID lysine and 2.94 (low), 3.25 (medium), or 3.57 (high) Mcal of ME/kg from 100 d of age until approximately 90 kg BW. Then, gilts were fed finisher diets containing 0.73 (low) or 0.85% (high) SID lysine and 2.94 (low), 3.26 (medium) or 3.59 (high) Mcal of ME/kg until 260 d of age. The medium SID lysine and medium-ME diets were based on an informal survey from the U.S. commercial swine industry to obtain average levels that are currently being formulated for developing gilts. Gilts were weighed and backfat thickness and loin area were recorded at the beginning of the trial and then every 28 d. Feed intake (FI) was recorded as feed disappearance within the pen at 2-wk intervals. Lysine (g) and ME (Mcal) consumed were calculated based on diet formulations. At approximately 260 d of age, gilts were slaughtered and warm carcass weight and fat thickness were recorded. There were no differences between lysine or ME levels for growth and body composition, except for backfat, which was slightly greater for gilts fed a high-ME diet. Gilts fed high-ME diets had a lower FI but a greater ME intake compared with gilts fed low ME ( < 0.05). Additionally, gilts fed the high-ME diet had lower FI and lysine intake per kilogram of BW gain when compared with gilts fed low- or medium-ME diets ( < 0.05). However, there was no difference in the megacalories consumed per kilogram of BW gain among treatments ( > 0.05). Carcasses from gilts fed the high-ME diet were 3.3 and 2.5 kg heavier than those from gilts fed the low- or medium-ME diets ( < 0.05). Despite significant differences in the lysine:ME ratio in the diets, no changes in growth or body composition occurred, likely due to compensatory changes in FI in response to dietary ME content. Caloric efficiency (Mcal to deposit 1 kg of BW) was similar among treatments.
Asunto(s)
Aminoácidos/farmacología , Alimentación Animal , Composición Corporal/efectos de los fármacos , Ingestión de Alimentos/efectos de los fármacos , Metabolismo Energético/efectos de los fármacos , Porcinos/crecimiento & desarrollo , Aminoácidos/análisis , Aminoácidos/metabolismo , Alimentación Animal/análisis , Animales , Composición Corporal/fisiología , Peso Corporal/efectos de los fármacos , Peso Corporal/fisiología , Dieta/veterinaria , Suplementos Dietéticos , Ingestión de Alimentos/fisiología , Metabolismo Energético/fisiología , Femenino , Íleon/metabolismo , Lisina/análisis , Lisina/metabolismo , Lisina/farmacología , Fenotipo , Porcinos/fisiologíaRESUMEN
Objetivo: Evaluar la efectividad de las infiltraciones postquirúrgicas de anestésico local solo y combinado con corticoide, para el tratamiento del dolor e inflamación en el postoperatorio temprano en pacientes intervenidos de menisco artroscópicamente. Material y método: Estudio clínico prospectivo randomizado de 60 pacientes a los que se les practicó menisectomía artroscópica. Finalizada la intervención, los pacientes fueron asignados aleatoriamente a uno de los dos grupos de estudio y se infiltró en un grupo 10 ml de clorhidrato de bupivacaína al 0,5% y en el otro el mismo anestésico, asociado a triamcinolona acetónido (solución de 40 mg). La percepción del dolor fue medida objetivamente por la Escala Visual Análoga (EVA), registrándose el dolor postquirúrgico a las 2, 4 y 24 horas y a los 15 días y al mes, después de la intervención. Resultados: No se encontraron diferencias significativas entre los diferentes grupos de estudio. Conclusión: La infiltración anestésica postquirúrgica en dosis única es un procedimiento muy útil para el manejo del dolor postoperatorio en pacientes que requieren la realización de una menisectomía artroscópica (AU)
Objective: To evaluate the effectiveness of postoperative local anesthetic infiltration alone and combined with corticosteroid for the treatment of pain and inflammation in the early postoperative period in patients undergoing arthroscopic meniscal pathology. Material and method: A prospective randomized clinical study, 60 patients who underwent arthroscopic meniscectomy. After surgery, patients were randomly assigned to one of two study groups and infiltrated a group 10 ml of bupivacaine hydrochloride 0.5% and on the other the same anesthetic, associated with triamcinolone acetonide (solution of 40 mg). Pain perception was objectively measured by the Visual Analog Scale (VAS), postoperative pain recorded at 2, 4 and 24 hours and 15 days and a month after the intervention. Results: No significant differences were found between the different groups. Conclusion: Postoperative anesthetic infiltration single dose is a very useful procedure for the management of postoperative pain in patients requiring arthroscopic meniscectomy performing (AU)